The DOI matches its Crossref record; 135 of the 135 references it cites were found in a registry or an index.
More Effective Nanomedicines through Particle Design
Open accessAbstract
Nanomedicine is an emerging field that applies concepts in nanotechnology to develop novel diagnostics and therapies. Physical and chemical properties of particles, including size, shape, modulus, surface charge and surface chemistry, play an important role in determining particle–cell interactions, cellular trafficking mechanisms, biodistribution, and pharmacokinetics. This discussion focuses on both nanoparticles and microparticles since microparticles can also provide many insights for the development of drug carriers and possess advantages over nanoparticles in certain applications. This review covers recent major advancement in the nanomedicine field and also highlights studies using the PRINT technology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
Chithrani, B. D., Ghazani, A. A., & Chan, W. C. W. (2006) · Nano Letters · doi:10.1021/nl052396o · Cited by 4,879
A Perspective on Cancer Cell Metastasis
Chaffer, C. L., & Weinberg, R. A. (2011) · Science · doi:10.1126/science.1203543 · Cited by 4,807
Nanostructures in Biodiagnostics
Rosi, N. L., & Mirkin, C. A. (2005) · Chemical Reviews · doi:10.1021/cr030067f · Cited by 4,603
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Regulated portals of entry into the cell
Conner, S. D., & Schmid, S. L. (2003) · Nature · doi:10.1038/nature01451 · Cited by 3,805
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Self-citationDischer, D. E., & Eisenberg, A. (2002) · Science · doi:10.1126/science.1074972 · Cited by 3,551
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918
Self-citationREJMAN, J., OBERLE, V., ZUHORN, I. S., & HOEKSTRA, D. (2004) · Biochemical Journal · doi:10.1042/bj20031253 · Cited by 2,864
Mechanisms of phagocytosis in macrophages
Aderem, A., & Underhill, D. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.593 · Cited by 2,854
Nanoparticle-mediated cellular response is size-dependent
Jiang, W., Kim, B. Y. S., Rutka, J. T., & Chan, W. C. W. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.30 · Cited by 2,776
Nanoparticle-based targeted drug delivery
Singh, R., & Lillard, J. W. (2009) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2008.12.004 · Cited by 2,734
Effect of Surface Properties on Nanoparticle–Cell Interactions
Verma, A., & Stellacci, F. (2010) · Small · doi:10.1002/smll.200901158 · Cited by 2,619
He, C., Hu, Y., Yin, L., Tang, C., & Yin, C. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.01.065 · Cited by 2,607
Shape effects of filaments versus spherical particles in flow and drug delivery
Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., & Discher, D. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.70 · Cited by 2,565
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Chithrani, B. D., & Chan, W. C. W. (2007) · Nano Letters · doi:10.1021/nl070363y · Cited by 2,286
Sahay, G., Alakhova, D. Y., & Kabanov, A. V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.036 · Cited by 2,181
Aptamers: An Emerging Class of Molecules That Rival Antibodies in Diagnostics
Jayasena, S. D. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.9.1628 · Cited by 2,144
Role of target geometry in phagocytosis
Champion, J. A., & Mitragotri, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600997103 · Cited by 2,074
Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation
Rosi, N. L., Giljohann, D. A., Thaxton, C. S., Lytton-Jean, A. K. R., Han, M. S., & Mirkin, C. A. (2006) · Science · doi:10.1126/science.1125559 · Cited by 1,988
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
Active targeting schemes for nanoparticle systems in cancer therapeutics
Byrne, J. D., Betancourt, T., & Brannon-Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,731
Self-citationVascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
Farokhzad, O. C., Cheng, J., Teply, B. A., Sherifi, I., Jon, S., Kantoff, P. W., Richie, J. P., & Langer, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601755103 · Cited by 1,663
Nanocarriers’ entry into the cell: relevance to drug delivery
Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,552
Guck, J., Schinkinger, S., Lincoln, B., Wottawah, F., Ebert, S., Romeyke, M., Lenz, D., Erickson, H. M., Ananthakrishnan, R., Mitchell, D., et al. (2005) · Biophysical Journal · doi:10.1529/biophysj.104.045476 · Cited by 1,417
Nanogels as Pharmaceutical Carriers: Finite Networks of Infinite Capabilities
Kabanov, A. V., & Vinogradov, S. V. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200900441 · Cited by 1,313
Nanomedicine—Challenge and Perspectives
Riehemann, K., Schneider, S. W., Luger, T. A., Godin, B., Ferrari, M., & Fuchs, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802585 · Cited by 1,305
GPI-anchored proteins are organized in submicron domains at the cell surface
Varma, R., & Mayor, S. (1998) · Nature · doi:10.1038/29563 · Cited by 1,209
Endocytic mechanisms for targeted drug delivery☆
BAREFORD, L., & SWAAN, P. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.008 · Cited by 1,033
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
Davis, M. E. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900015y · Cited by 977
Size and shape effects in the biodistribution of intravascularly injected particles
Decuzzi, P., Godin, B., Tanaka, T., Lee, S.-Y., Chiappini, C., Liu, X., & Ferrari, M. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.014 · Cited by 965
Folate-mediated delivery of macromolecular anticancer therapeutic agents
Lu, Y., & Low, P. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00042-x · Cited by 941
Cell-specific targeting of nanoparticles by multivalent attachment of small molecules
Weissleder, R., Kelly, K., Sun, E. Y., Shtatland, T., & Josephson, L. (2005) · Nature Biotechnology · doi:10.1038/nbt1159 · Cited by 904
Nanoparticle-Aptamer Bioconjugates
Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T.-N. T., LaVan, D. A., & Langer, R. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2550 · Cited by 897
Synthetic Multivalent Ligands as Probes of Signal Transduction
Kiessling, L. L., Gestwicki, J. E., & Strong, L. E. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502794 · Cited by 864
The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent
Desai, M. P., Labhasetwar, V., Walter, E., Levy, R. J., & Amidon, G. L. (1997) · Pharmaceutical Research · doi:10.1023/a:1012126301290 · Cited by 858
Direct Fabrication and Harvesting of Monodisperse, Shape-Specific Nanobiomaterials
Rolland, J. P., Maynor, B. W., Euliss, L. E., Exner, A. E., Denison, G. M., & DeSimone, J. M. (2005) · Journal of the American Chemical Society · doi:10.1021/ja051977c · Cited by 852
Self-citationDischer, D. E., & Ahmed, F. (2006) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.8.061505.095838 · Cited by 844
Strategies for the intracellular delivery of nanoparticles
Chou, L. Y. T., Ming, K., & Chan, W. C. W. (2011) · Chem. Soc. Rev. · doi:10.1039/c0cs00003e · Cited by 811
Making polymeric micro- and nanoparticles of complex shapes
Champion, J. A., Katare, Y. K., & Mitragotri, S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705326104 · Cited by 747
Local Actin Polymerization and Dynamin Recruitment in SV40-Induced Internalization of Caveolae
Pelkmans, L., Püntener, D., & Helenius, A. (2002) · Science · doi:10.1126/science.1069784 · Cited by 720
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers
Gu, F., Zhang, L., Teply, B. A., Mann, N., Wang, A., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711714105 · Cited by 715
Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles
Choi, C. H. J., Alabi, C. A., Webster, P., & Davis, M. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914140107 · Cited by 699
Aptamers come of age – at last
Bunka, D. H. J., & Stockley, P. G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1458 · Cited by 695
Exploring the Genomes of Cancer Cells: Progress and Promise
Stratton, M. R. (2011) · Science · doi:10.1126/science.1204040 · Cited by 693
Gene Regulation with Polyvalent siRNA−Nanoparticle Conjugates
Giljohann, D. A., Seferos, D. S., Prigodich, A. E., Patel, P. C., & Mirkin, C. A. (2009) · Journal of the American Chemical Society · doi:10.1021/ja808719p · Cited by 637
Daniels, T. R., Delgado, T., Rodriguez, J. A., Helguera, G., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.010 · Cited by 634
Hu-Lieskovan, S., Heidel, J. D., Bartlett, D. W., Davis, M. E., & Triche, T. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0565 · Cited by 567
Kolishetti, N., Dhar, S., Valencia, P. M., Lin, L. Q., Karnik, R., Lippard, S. J., Langer, R., & Farokhzad, O. C. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011368107 · Cited by 565
Targeting of nanoparticles to the clathrin-mediated endocytic pathway
Harush-Frenkel, O., Debotton, N., Benita, S., & Altschuler, Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.11.135 · Cited by 564
Muro, S., Garnacho, C., Champion, J. A., Leferovich, J., Gajewski, C., Schuchman, E. H., Mitragotri, S., & Muzykantov, V. R. (2008) · Molecular Therapy · doi:10.1038/mt.2008.127 · Cited by 564
Stealth nanoparticles: High density but sheddable PEG is a key for tumor targeting
Li, S.-D., & Huang, L. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.016 · Cited by 562
Merkel, T. J., Jones, S. W., Herlihy, K. P., Kersey, F. R., Shields, A. R., Napier, M., Luft, J. C., Wu, H., Zamboni, W. C., Wang, A. Z., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010013108 · Cited by 548
Self-citationSeven challenges for nanomedicine
Sanhai, W. R., Sakamoto, J. H., Canady, R., & Ferrari, M. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.114 · Cited by 538
Lamaze, C., Dujeancourt, A., Baba, T., Lo, C. G., Benmerah, A., & Dautry-Varsat, A. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00212-x · Cited by 525
Yoo, J.-W., Chambers, E., & Mitragotri, S. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791920496 · Cited by 521
The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells
Daniels, T. R., Delgado, T., Helguera, G., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.006 · Cited by 518
Sequestration of GPI-Anchored Proteins in Caveolae Triggered by Cross-Linking
Mayor, S., Rothberg, K. G., & Maxfield, F. R. (1994) · Science · doi:10.1126/science.7516582 · Cited by 510
Biomechanics approaches to studying human diseases
Lee, G. Y. H., & Lim, C. T. (2007) · Trends in Biotechnology · doi:10.1016/j.tibtech.2007.01.005 · Cited by 485
Oh, P., Li, Y., Yu, J., Durr, E., Krasinska, K. M., Carver, L. A., Testa, J. E., & Schnitzer, J. E. (2004) · Nature · doi:10.1038/nature02580 · Cited by 475
Panyam, J., & Labhasetwar, V. (2003) · Pharmaceutical Research · doi:10.1023/a:1022219003551 · Cited by 466
Polymer particle shape independently influences binding and internalization by macrophages
Sharma, G., Valenta, D. T., Altman, Y., Harvey, S., Xie, H., Mitragotri, S., & Smith, J. W. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.07.116 · Cited by 466
Venturoli, D., & Rippe, B. (2005) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00171.2004 · Cited by 461
The adhesive strength of non-spherical particles mediated by specific interactions
Decuzzi, P., & Ferrari, M. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.05.024 · Cited by 452
Yamamoto, Y., Nagasaki, Y., Kato, Y., Sugiyama, Y., & Kataoka, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00451-5 · Cited by 442
Rothberg, K. G., Ying, Y. S., Kolhouse, J. F., Kamen, B. A., & Anderson, R. G. (1990) · The Journal of cell biology · doi:10.1083/jcb.110.3.637 · Cited by 441
Transferrin/transferrin receptor‐mediated drug delivery
Li, H., & Qian, Z. M. (2002) · Medicinal Research Reviews · doi:10.1002/med.10008 · Cited by 441
Fang, C., Shi, B., Pei, Y.-Y., Hong, M.-H., Wu, J., & Chen, H.-Z. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.08.002 · Cited by 424
Harush-Frenkel, O., Rozentur, E., Benita, S., & Altschuler, Y. (2008) · Biomacromolecules · doi:10.1021/bm700535p · Cited by 405
Aptamer Nano-flares for Molecular Detection in Living Cells
Zheng, D., Seferos, D. S., Giljohann, D. A., Patel, P. C., & Mirkin, C. A. (2009) · Nano Letters · doi:10.1021/nl901517b · Cited by 401
Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target
Beningo, K. A., & Wang, Y.-L. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.4.849 · Cited by 389
Heidel, J. D., Yu, Z., Liu, J. Y.-C., Rele, S. M., Liang, Y., Zeidan, R. K., Kornbrust, D. J., & Davis, M. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701458104 · Cited by 382
Imparting size, shape, and composition control of materials for nanomedicine
Euliss, L. E., DuPont, J. A., Gratton, S., & DeSimone, J. (2006) · Chemical Society Reviews · doi:10.1039/b600913c · Cited by 381
Self-citationInhibition of HIV Fusion with Multivalent Gold Nanoparticles
Bowman, M.-C., Ballard, T. E., Ackerson, C. J., Feldheim, D. L., Margolis, D. M., & Melander, C. (2008) · Journal of the American Chemical Society · doi:10.1021/ja710321g · Cited by 371
Heath, J. R., & Davis, M. E. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.59.061506.185523 · Cited by 354
Transferrin-Containing, Cyclodextrin Polymer-Based Particles for Tumor-Targeted Gene Delivery
Bellocq, N. C., Pun, S. H., Jensen, G. S., & Davis, M. E. (2003) · Bioconjugate Chemistry · doi:10.1021/bc034125f · Cited by 350
Allen, T. M., Austin, G. A., Chonn, A., Lin, L., & Lee, K. C. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90268-d · Cited by 345
Tumor-targeted Delivery of siRNA by Self-assembled Nanoparticles
Li, S.-D., Chen, Y.-C., Hackett, M. J., & Huang, L. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300323 · Cited by 333
Wang, J., Tian, S., Petros, R. A., Napier, M. E., & DeSimone, J. M. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1043177 · Cited by 330
Self-citationFunction of Rho family proteins in actin dynamics during phagocytosis and engulfment
Chimini, G., & Chavrier, P. (2000) · Nature Cell Biology · doi:10.1038/35036454 · Cited by 329
Macrophages Recognize Size and Shape of Their Targets
Doshi, N., & Mitragotri, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010051 · Cited by 321
Panyam, J., Sahoo, S. K., Prabha, S., Bargar, T., & Labhasetwar, V. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00295-3 · Cited by 308
Oh, P., Borgström, P., Witkiewicz, H., Li, Y., Borgström, B. J., Chrastina, A., Iwata, K., Zinn, K. R., Baldwin, R., Testa, J. E., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1292 · Cited by 300
Bacterial morphology: why have different shapes?
Young, K. D. (2007) · Current Opinion in Microbiology · doi:10.1016/j.mib.2007.09.009 · Cited by 294
Physicochemical and Biological Characterization of Targeted, Nucleic Acid-Containing Nanoparticles
Bartlett, D. W., & Davis, M. E. (2007) · Bioconjugate Chemistry · doi:10.1021/bc0603539 · Cited by 283
Li, S.-D., & Huang, L. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060039w · Cited by 282
The Receptor-Mediated Endocytosis of Nonspherical Particles
Decuzzi, P., & Ferrari, M. (2008) · Biophysical Journal · doi:10.1529/biophysj.107.120238 · Cited by 278
Polymer particles that switch shape in response to a stimulus
Yoo, J.-W., & Mitragotri, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000346107 · Cited by 275
Lai, S. K., Hida, K., Man, S. T., Chen, C., Machamer, C., Schroer, T. A., & Hanes, J. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.02.021 · Cited by 264
Ishida, O., Maruyama, K., Tanahashi, H., Iwatsuru, M., Sasaki, K., Eriguchi, M., & Yanagie, H. (2001) · Pharmaceutical Research · doi:10.1023/a:1010960900254 · Cited by 257
Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows
Lee, S.-Y., Ferrari, M., & Decuzzi, P. (2009) · Nanotechnology · doi:10.1088/0957-4484/20/49/495101 · Cited by 257
Nanoparticle–aptamer bioconjugates for cancer targeting
Farokhzad, O. C., Karp, J. M., & Langer, R. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.3.311 · Cited by 256
Chono, S., Li, S.-D., Conwell, C. C., & Huang, L. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.07.006 · Cited by 238
Designer Biomaterials for Nanomedicine
Doshi, N., & Mitragotri, S. (2009) · Advanced Functional Materials · doi:10.1002/adfm.200901538 · Cited by 238
Qaddoumi, M. G., Ueda, H., Yang, J., Davda, J., Labhasetwar, V., & Lee, V. H. L. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000022411.47059.76 · Cited by 229
Merkel, T. J., Herlihy, K. P., Nunes, J., Orgel, R. M., Rolland, J. P., & DeSimone, J. M. (2010) · Langmuir · doi:10.1021/la903890h · Cited by 228
Self-citationTargeted Nanomedicines: Effective Treatment Modalities for Cancer, AIDS and Brain Disorders
Muthu, M. S., & Singh, S. (2009) · Nanomedicine · doi:10.2217/17435889.4.1.105 · Cited by 225
Targeted Drugs and Nanomedicine: Present and Future
Debbage, P. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787002870 · Cited by 213
McIntosh, D. P., Tan, X.-Y., Oh, P., & Schnitzer, J. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251662398 · Cited by 210
Efficient Oncogene Silencing and Metastasis Inhibition via Systemic Delivery of siRNA
Li, S.-D., Chono, S., & Huang, L. (2008) · Molecular Therapy · doi:10.1038/mt.2008.51 · Cited by 198
Garanger, E., Boturyn, D., & Dumy, P. (2007) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152007781668706 · Cited by 185
Schnitzer, J. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00141-7 · Cited by 176
Sahay, G., Kim, J. O., Kabanov, A. V., & Bronich, T. K. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2009.09.101 · Cited by 170
Nanostructured Materials and Nanotechnology
(2002) · Elsevier eBooks · doi:10.1016/b978-0-12-513920-5.x5000-8 · Cited by 168
Design maps for nanoparticles targeting the diseased microvasculature
Decuzzi, P., & Ferrari, M. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.09.025 · Cited by 168
Potent Engineered PLGA Nanoparticles by Virtue of Exceptionally High Chemotherapeutic Loadings
Enlow, E. M., Luft, J. C., Napier, M. E., & DeSimone, J. M. (2011) · Nano Letters · doi:10.1021/nl104117p · Cited by 165
Self-citationThe association of silicon microparticles with endothelial cells in drug delivery to the vasculature
Serda, R. E., Gu, J., Bhavane, R. C., Liu, X., Chiappini, C., Decuzzi, P., & Ferrari, M. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.019 · Cited by 163
Tunable Bifunctional Silyl Ether Cross-Linkers for the Design of Acid-Sensitive Biomaterials
Parrott, M. C., Luft, J. C., Byrne, J. D., Fain, J. H., Napier, M. E., & DeSimone, J. M. (2010) · Journal of the American Chemical Society · doi:10.1021/ja108568g · Cited by 158
Self-citationEfficient gene silencing in metastatic tumor by siRNA formulated in surface-modified nanoparticles
Li, S., Chono, S., & Huang, L. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.11.002 · Cited by 151
Tekle, C., van Deurs, B., Sandvig, K., & Iversen, T. (2008) · Nano Letters · doi:10.1021/nl0803848 · Cited by 150
Nanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosis
Bhattacharyya, S., Bhattacharya, R., Curley, S. A., McNiven, M. A., & Mukherjee, P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006507107 · Cited by 147
Shape-Specific, Monodisperse Nano-Molding of Protein Particles
Kelly, J. Y., & DeSimone, J. M. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8014428 · Cited by 145
Self-citationTemplated Spherical High Density Lipoprotein Nanoparticles
Thaxton, C. S., Daniel, W. L., Giljohann, D. A., Thomas, A. D., & Mirkin, C. A. (2009) · Journal of the American Chemical Society · doi:10.1021/ja808856z · Cited by 122
Wu, K., Liu, J., Johnson, R. N., Yang, J., & Kopec̆ek, J. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200906232 · Cited by 120
Nakagawa, O., Ming, X., Huang, L., & Juliano, R. L. (2010) · Journal of the American Chemical Society · doi:10.1021/ja102635c · Cited by 120
Targeted Nanoparticles Deliver siRNA to Melanoma
Chen, Y., Bathula, S. R., Yang, Q., & Huang, L. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.222 · Cited by 119
Gratton, S. E. A., Napier, M. E., Ropp, P. A., Tian, S., & DeSimone, J. M. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9654-8 · Cited by 100
Self-citationNovel Cationic Lipid That Delivers siRNA and Enhances Therapeutic Effect in Lung Cancer Cells
Chen, Y., Sen, J., Bathula, S. R., Yang, Q., Fittipaldi, R., & Huang, L. (2009) · Molecular Pharmaceutics · doi:10.1021/mp800136v · Cited by 96
Design of bio-mimetic particles with enhanced vascular interaction
Lee, S., Mauro Ferrari, B., & Decuzzi, P. (2009) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2009.05.012 · Cited by 95
Nanoparticle-Mediated IgE−Receptor Aggregation and Signaling in RBL Mast Cells
Huang, Y., Liu, H., Xiong, X., Chen, Y., & Tan, W. (2009) · Journal of the American Chemical Society · doi:10.1021/ja907125t · Cited by 87
Nanoscale interfaces to biology
Park, S., & Hamad‐Schifferli, K. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.06.186 · Cited by 73
Haloperidol-associated Stealth Liposomes
Mukherjee, A., Prasad, T. K., Rao, N. M., & Banerjee, R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409723200 · Cited by 71
Wu, M., Fan, J., Gunning, W. T., & Ratnam, M. (1997) · The Journal of Membrane Biology · doi:10.1007/s002329900277 · Cited by 69
Zhang, H., Nunes, J. K., Gratton, S. E. A., Herlihy, K. P., Pohlhaus, P. D., & DeSimone, J. M. (2009) · New Journal of Physics · doi:10.1088/1367-2630/11/7/075018 · Cited by 66
Self-citationNanoparticle-Cell Interactions: Drug Delivery Implications
Harush-Frenkel, O., Altschuler, Y., & Benita, S. (2008) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v25.i6.10 · Cited by 62
Chiu, G. N. C., Edwards, L., Kapanen, A. I., Malinen, M. M., Dragowska, W. H., Warburton, C., Chikh, G., Fang, K. Y. Y., Tan, S., Sy, J., et al. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0159 · Cited by 59
Cancer Research and the $90 Billion Metaphor
Marshall, E. (2011) · Science · doi:10.1126/science.331.6024.1540-a · Cited by 46
Peptides for In Vivo Target-Specific Cancer Imaging
Ferro‐Flores, G., Ramı́rez, F. D. M., Meléndez‐Alafort, L., & Santos‐Cuevas, C. (2010) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955710791112596 · Cited by 41
Nanotechnology for synthetic high-density lipoproteins
Luthi, A. J., Patel, P. C., Ko, C. H., Mutharasan, R. K., Mirkin, C. A., & Thaxton, C. S. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.10.006 · Cited by 35
Challenging Nature‘S Monopoly on The Creation of Well-Defined Nanoparticles
Jeong, W., Napier, M. E., & DeSimone, J. M. (2010) · Nanomedicine · doi:10.2217/nnm.10.34 · Cited by 30
Self-citationDesigned Auto-assembly of Nanostreptabodies for Rapid Tissue-specific Targeting in Vivo
Valadon, P., Darsow, B., Buss, T., Czarny, M., Griffin, N. M., Nguyen, H. N., Oh, P., Borgström, P., Chrastina, A., & Schnitzer, J. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.061838 · Cited by 23
Cited by
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
Nanomaterials for In Vivo Imaging
Smith, B. R., & Gambhir, S. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00073 · Cited by 1,075
Ernsting, M. J., Murakami, M., Roy, A., & Li, S.-D. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.013 · Cited by 1,012
Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling
Sahay, G., Querbes, W., Alabi, C., Eltoukhy, A., Sarkar, S., Zurenko, C., Karagiannis, E., Love, K., Chen, D., Zoncu, R., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2614 · Cited by 948
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come
Yingchoncharoen, P., Kalinowski, D. S., & Richardson, D. R. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012070 · Cited by 744
Metadata
- Authors
- Wang, J., Byrne, J. D., Napier, M. E., & DeSimone, J. M.
- Venue
- Small
- Publisher
- Wiley
- Published
- 2011-06-22
- Volume
- 7
- Issue
- 14
- Pages
- 1919-1931
- ISSN
- 1613-6810 (ISSN-L)
- 1613-6829
- OpenAlex
- W2165031969
- Cited by
- 466
- References
- 135
- FWCI
- 15.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.